MapLight Therapeutics to Participate in Upcoming Investor Conferences

SAN FRANCISCO and BOSTON, March 02, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT) today announced that members of its management team will participate in the following investor conferences:

Event: Jefferies 2026 Biotech on the Beach Summit (Miami, FL)
Date: Tuesday, March 10^th
Format: Hosting 1x1 meetings

Event: Leerink 2026 Global Healthcare Conference (Miami, FL)
Date: Wednesday, March 11^th
Format: Presenting and hosting 1x1 meetings

Event: Stifel 2026 Virtual CNS Forum
Date: Wednesday, March 18^th
Format: Presenting and hosting 1x1 meetings

Where available, access to the live webcasts of these events, as well as archived recordings, will be posted under the “Events & Presentations” page on the Investor section of the company’s website at https://ir.maplightrx.com/news-events/events-presentations.

About MapLight Therapeutics

MapLight Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders. The company was founded by globally recognized leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The company’s discovery platform holds the potential to fill this void by identifying neural circuits causally linked to disease and targeting those circuits for therapeutic modulation. 

For more information, please visit www.maplightrx.com.

For investor inquiries: [email protected]

For media inquiries: [email protected]

You May Also Be Interested In

• Rocket Lab Satellite Platforms Built for MDA Space Successfully Reach Orbit, Supporting Globalstar Direct-to-Device Communications Services
• DREYER'S GRAND ICE CREAM, INC. ISSUES VOLUNTARY RECALL ON SELECT OUTSHINE FRUIT BARS DUE TO POSSIBLE FOREIGN MATTER CONTAMINATION
• Bitcoin News Today: MemeToro Presale Momentum Builds as BTC Holds $64,200 Ahead of Fed Rate Decision